Theravance Biopharma, Inc. (FRA:0TB)

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $19.99M USD in the quarter ending September 30, 2025, with 18.51% growth. This brings the company's revenue in the last twelve months to $80.33M, up 27.12% year-over-year. In the year 2024, Theravance Biopharma had annual revenue of $64.38M with 12.12% growth.

• Revenue (ttm): $80.33M
• Revenue Growth: +27.12%
• P/S Ratio: 12.49
• Revenue / Employee: $828.11K
• Employees: 97
• Market Cap: 854.77M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	64.38M	6.96M	12.12%
Dec 31, 2023	57.42M	6.08M	11.84%
Dec 31, 2022	51.35M	-3.97M	-7.17%
Dec 31, 2021	55.31M	-16.55M	-23.03%
Dec 31, 2020	71.86M	-1.56M	-2.12%
Dec 31, 2019	73.41M	13.04M	21.61%
Dec 31, 2018	60.37M	44.98M	292.37%
Dec 31, 2017	15.39M	-33.26M	-68.37%
Dec 31, 2016	48.65M	6.52M	15.48%
Dec 31, 2015	42.13M	30.44M	260.42%
Dec 31, 2014	11.69M	11.46M	5,071.68%
Dec 31, 2013	226.00K	-129.92M	-99.83%
Dec 31, 2012	130.15M	-	-